Medline Inc.’s long-delayed initial public offering is on track to raise the most of any listing this year, as investors keen on the medical supply company’s business model look past its rocky path back to the public markets.
The company, in which Blackstone Inc., Carlyle Group Inc. and Hellman & Friedman acquired a majority stake via a $34 billion deal in 2021, is seeking on Tuesday to raise as much as $5.37 billion in the listing. That amount would make it the year’s biggest US IPO at the bottom of the price range, and at the top, the ...
